News Focus
News Focus
icon url

Zadie420

12/25/23 12:47 PM

#659042 RE: flipper44 #659041

I like 1 & 2. Forget about 3.
icon url

meirluc

12/25/23 1:13 PM

#659044 RE: flipper44 #659041

Thank you Flipper and DD for your answers. If we obtain
enough evidence of CSF-1R's utility in the combo and/or
that keytruda is a plus, than Merck is the BP with the
partnership/BO advantage. Otherwise I am looking forward
to a fierce BP competition for NWBO's favors and that is also
not a bad alternative.
icon url

iclight

12/25/23 7:09 PM

#659091 RE: flipper44 #659041

More bullshit breadcrumbs. When will one lead to anything?